Dolby Laboratories, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
Dolby Laboratories, Inc. (DLB) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss of $691.00 thousand as of 2024-06-28, per its 10-Q filed 2024-08-07.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss · last filed 2024-11-19
- 2024-06-28: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $691.00K.
- 2024-03-29: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $793.00K.
- 2023-12-29: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $1.06M.
- 2023-09-29: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $1.95M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss |
|---|---|
| 2024-06-28 | $691.00K 10-Q · filed 2024-08-07 |
| 2024-03-29 | $793.00K 10-Q · filed 2024-05-02 |
| 2023-12-29 | $1.06M 10-Q · filed 2024-02-02 |
| 2023-09-29 | $1.95M 10-K · filed 2024-11-19 |
| 2023-06-30 | $2.13M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.52M 10-Q · filed 2023-05-05 |
| 2022-12-30 | $3.28M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $1.10M 10-K · filed 2023-11-17 |
| 2022-07-01 | $372.00K 10-Q · filed 2022-08-09 |
| 2022-04-01 | $130.00K 10-Q · filed 2022-05-05 |